|
Kinase Screening & Profiling Trends 2010
Published May 2010
This market report summarizes the results of HTStec’s 4th industry-wide global web-based benchmarking survey on kinase screening and profiling carried out in April 2010.
More>>
|
|
|
|
Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine
Published April 2010
This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010. The data presented herein are based on primary market surveys from a worldwide respondent pool of industry participants active in the stem cells field.
More>>
|
|
|
|
Toxicity Screening 2009
Published
Select Biosciences has focused on cardiotoxicity, hERG channel blockade and associated Torsades de pointes arrhythmias technology and market analysis in this timely industry report. Also presented extensively in this report are pharmaceutical industry and regulatory authority perspectives providing a technology, market, end-user, and regulatory trends report.
More>>
|
|
|
|
TR-FRET Based Assay Trends 2007
Published
This market report summarizes the results of HTStec’s global pharma and biotech web-based benchmarking survey on TR-FRET based assays and reagents carried out in December 2007.
The study was initiated to comprehensively document current practices, requirements and future trends for TR-FRET based assay reagent technologies. The questions were aimed at providing vendors with updated information on the use of theses assays and direction as to where they should focus their future R & D efforts o
More>>
|
|
|
|
Compound Management Trends 2008
Published
This market report summarizes the results of HTStec’s second global pharma and biotech web-based benchmarking survey on compound management carried out in January 2008.
The study was initiated to gain a better awareness of the metrics behind current and future compound management (CM) practices within pharmaceutical, biotech and other life science research establishments. The survey focus was on liquid stores, with particular emphasis on learning how the makeup of corporate compound collectio
More>>
|
|
|
|
High-Content Analysis 2007
Published April 2007
This report presents an industry analysis of the High-Content Analysis Marketplace in both qualitative and quantitative terms. High-Content Analysis involves the use of instrumentation, reagents, and informatics to perform multi-parametric analysis of biological systems—ie., lots of different cellular parameters studied in parallel.
More>>
|
|
|
|
Fluorescence Lifetime Trends 2007
Published March 2007
This market report summarizes the results of HTStec’s global web-based benchmarking survey on FLT. Amongst other subjects, the survey investigated the following aspects of FLT-based measurements; general perception; current level of awareness; current level of use; areas where FLT has been applied; awareness and feedback on commercial instruments.
More>>
|
|
|
|
Kinase Screening Profiling Trends 2006
Published September 2006
This market report summarizes the results of the second industry-wide global Pharma and Biotech web-based benchmarking survey on kinase screening and profiling. The objective of this study was to document current practices and preferences and to understand future user requirements (particularly in respect of the need for outsourced services) in kinase screening and profiling.
More>>
|
|
|
|
Ion Channel Trends 2006
Published July 2006
This market report summarizes the results of the third annual global Pharma/Biotech and Academic web-based benchmarking survey on ion channels. The objectives of this study were to better understand the impact of automated patch clamping (APC) and to gauge if its use will widen over the coming years, and to determine current interest and future requirements for ion channel screening using primary neural cells.
More>>
|
|
|
|
U.S. and Western European In Silico ADME/Tox Products Market 2006
Published June 2006
In Silico predictive ADME/Tox screening is one of the hottest areas in drug discovery. It is widely perceived that the early screening of chemical entities can significantly reduce the expensive costs associated with late stage failures of drugs due to poor ADME/Tox properties. This market research report from Select Biosciences provides and up-to-date overview and analysis of technology, business, regulatory trends and key product profiles.
More>>
|
|
|
|
Automated Low Volume Dispensing Trends 2006
Published June 2006
This market report summarizes the results of a comprehensive global Pharma/Biotech and Academia web-based survey on automated low volume (nanoliter) dispensing.
More>>
|
|
|
|
Label Free Detection Trends 2006
Published April 2006
This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on the current and future status of label free detection and its applications. The survey looked at various points including current or planned use of label free detection; new technology awareness; application and technical requirements.
More>>
|
|
|
|
Cell Culture Vessels Trends 2006
Published February 2006
This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on the current and future status of cell culture vessel trends.
More>>
|
|
|
|
TR-FRET Based Assay Trends
Published October 2005
This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on TR-FRET based assays. The survey looked at various points including current use of TR-FRET based assays and other generic assay technologies; reasons for choosing TR-FRET based assays over alternative assays and vice versa; whether TR-FRET was a preferred assay technology and usage/spending today; current expertise in multiple assay technologies.
More>>
|
|
|
|
hERG: Technology and Market Analysis
Published September 2005
hERG: Technology and Market Analysis focuses on hERG, a potassium channel that is abundant in the cardiac muscle. hERG is a major component of the toxicity observed with many pharmaceuticals and it is estimated that 25-40% of all lead compounds show some activity towards the hERG ion channel.
More>>
|
|
|
|
Drug Targets from Genomics - Evolving Tools for Discovery
Published August 2005
Drug Targets from Genomics: Evolving Tools for Discovery seeks to examine the roles omic technologies play in pharma R&D, to assess their value to pharma, and to predict their future role and value. This Report analyzes current and projected revenues from sales of omic technology-based products (reagents and consumables), which in 2004 totaled nearly $1.5 billion.
More>>
|
|
|
|
Model Organisms in Drug Discovery and Development: An Industry Analysis
Published June 2005
The report provides comparisons of the various model organisms being deployed currently by the pharmaceutical and biotechnology companies. It also presents the value proposition presented by each of the model systems to the drug discovery and development marketplace.
More>>
|
|
|
|
Microplate Instrument Trends
Published June 2005
This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on microplate instrumentation trends carried out in May 2005.
More>>
|
|
|
|
Protein-Protein Interactions as Drug Targets
Published January 2005
The area of protein-protein interaction has been growing at a tremendous rate. The market is expected to reach over $50 billion by year 2010. Protein-protein interaction targeting activities are increasing and are expected to bring success in the near future. Protein-protein interactions are critical for normal and tumor cells signal transduction pathways, making them attractive targets for developing therapeutic molecules.
More>>
|
|
|
|
Compound Management Trends
Published December 2004
This market report summarizes the results of a global benchmarking web-based survey of Pharma and Biotech compound management groups. The objective of the study being to comprehensively document current practices, issues and future trends in compound management, with a particular focus on compound quality control and just-in-time compound delivery.
More>>
|
|
|